CN Patent
CN116437921A — 鞘氨醇-1-磷酸酯受体激动剂的用途
Assigned to LG Chem Ltd · Expires 2023-07-14 · 3y expired
What this patent protects
本发明涉及化学式1的化合物或其药学上可接受的盐用于预防或治疗特应性皮炎的用途。
USPTO Abstract
本发明涉及化学式1的化合物或其药学上可接受的盐用于预防或治疗特应性皮炎的用途。
Drugs covered by this patent
- Velsipity (Etrasimod Arginine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.